MedTrace Logo

Steroids, Hyaluronic Acid or Platelet Rich Plasma Versus Placebo for the Knee Osteoarthritis

NCT02776514 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-02-07

No results posted yet for this study

Summary

This study investigates clinical outcome and imaging outcome parameters after intraarticular injection of steroids, platelet-rich-plasma (prp), hyaluronic acid or placebo in patients with early osteoarthritis of the knee joint.

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

Triamcort

Fluoroscopic guided injection in the knee joint

DRUG

Platelet-rich-plasma

DRUG

Suplasyn1

DRUG

Placebo

Sponsors & Collaborators

  • Stiftung für Rheumaforschung Zurich

    collaborator UNKNOWN

  • Stiftung Marie-Lou Ringgenberg Bern

    collaborator UNKNOWN

  • Balgrist University Hospital

    lead OTHER

Principal Investigators

  • Andrea B Rosskopf, MD · Radiology University Hospital Balgrist

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02776514 on ClinicalTrials.gov